FUT4 and acute myeloid leukemia: We did not, however, find significant differences in basal proliferation rates between AML-M1 and AML-M5 patient cells or cells with high or low CD15 expression (data not shown), indicating that factors besides proliferation rate play a sensitizing role toward AVA.